Fractyl Health (GUTS) Accumulated Depreciation (2023 - 2025)
Fractyl Health (GUTS) reported Accumulated Depreciation of $2.7 million for Q4 2025, up 70.78% year-on-year from $1.6 million in Q4 2024, and up 70.78% quarter-over-quarter from $1.6 million in Q4 2024.
Fractyl Health (GUTS) has 3 years of Accumulated Depreciation data on file, last reported at $2.7 million in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Depreciation rose 70.78% year-over-year to $2.7 million; the trailing twelve-month figure through Dec 2025 stood at $2.7 million (up 70.78% YoY), and the FY2025 full-year result was $2.7 million, up 70.78% from the prior year.
- Accumulated Depreciation for Q4 2025 stood at $2.7 million, up from $1.6 million in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $4.8 million in Q4 2023 and bottomed at $1.6 million in Q4 2024.
- A 3-year average of $3.0 million and a median of $2.7 million in 2025 frame the typical range for Accumulated Depreciation.
- Across the five-year window, Accumulated Depreciation sank 66.98% in 2024 and jumped 70.78% in 2025, its largest moves.
- Tracing GUTS's Accumulated Depreciation over 3 years: stood at $4.8 million in 2023, then sank by 66.98% to $1.6 million in 2024, then jumped by 70.78% to $2.7 million in 2025.
- According to Business Quant data, Accumulated Depreciation over the past three periods registered $2.7 million, $1.6 million, and $4.8 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.72 Mn |
| Dec 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 4.83 Mn |